UniSuper Management Pty Ltd Acquires 23,581 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

UniSuper Management Pty Ltd grew its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% during the fourth quarter, HoldingsChannel reports. The firm owned 184,745 shares of the pharmacy operator’s stock after buying an additional 23,581 shares during the quarter. UniSuper Management Pty Ltd’s holdings in Walgreens Boots Alliance were worth $1,724,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. First Financial Corp IN boosted its position in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at $26,000. Riverview Trust Co boosted its holdings in shares of Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares in the last quarter. Venturi Wealth Management LLC bought a new stake in Walgreens Boots Alliance during the 4th quarter worth $28,000. Finally, TD Private Client Wealth LLC increased its holdings in Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Trading Up 0.3 %

NASDAQ:WBA opened at $11.19 on Monday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $21.74. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.67 billion, a price-to-earnings ratio of -1.09, a PEG ratio of 1.31 and a beta of 0.62. The firm has a fifty day simple moving average of $10.83 and a two-hundred day simple moving average of $9.92.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the business posted $0.66 EPS. Analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Wall Street Analyst Weigh In

WBA has been the topic of several research reports. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and cut their price target for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Finally, Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.